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Abstract—Normal values, as well as determining factors, for
the 6-minute walk test are available for nondisabled adults, but
less is known about individuals with Parkinson disease (PD).
This study created a PD-specific reference equation and identi-
fied unique factors associated with 6-minute walk distance
(6MWD). Eighty individuals (mean +/– standard deviation
[SD] age: 66.3 +/– 9.8 yr) with mild to moderate PD underwent
a neurological examination and completed a small battery of
tests to assess their balance confidence, fall risk, mobility, and
balance. Their mean +/– SD 6MWD was 394.1 +/– 98.4 m
(95% confidence interval: 370.0–418.1). Stepwise multiple
regression analysis demonstrated that timed up-and-go (TUG)
test, one-leg stance (OLS) test, and sex were significant inde-
pendent contributors to 6MWD and accounted for 56.6% of the
variance. The resulting PD-specific regression equation is
6MWDpred = 543.06 + (–10.83 × TUG) + (2.04 × OLS) +
(–44.44 × sex). (For sex, 0 = female, 1 = male.) Future inter-
pretation of 6MWD in individuals with PD may be enhanced if
expressed as a percentage of the value predicted utilizing this
reference equation.
Key words: 6-minute walk distance, exercise test, Freezing of
Gait questionnaire, functional capacity, one-leg stance test,
Parkinson disease, reference equation, timed up-and-go test,
UPDRS, walking.
INTRODUCTION
The 6-minute walk test is widely used in clinical set-
tings to assess functional exercise, often as an outcome
measurement for evaluating an intervention [1]. Refer-
ence equations for 6-minute walk distance (6MWD) are
available [2–3] yet were developed using data from non-
disabled older adults. Utilizing these equations for indi-
viduals with motor impairment, such as Parkinson disease
(PD), may not be appropriate. For example, Garber and
Friedman [4] reported 6MWDs in individuals with PD
that were 42 percent of that predicted by one such refer-
ence equation [2], suggesting that factors unique to PD are
not considered in these existing equations. Canning et al.
[5], as well as work from our laboratory [6], have identi-
fied certain variables that explain large portions of vari-
ance in 6MWD and therefore contribute to the observed
reduced distances. These variables broadly comprise
measures of parkinsonian symptoms and functional
mobility (i.e., Berg Balance Score, timed up-and-go
[TUG] test), which are distinct from the variables con-
tained in the reference equations for nondisabled adults
(e.g., anthropometrics, age, and sex) [2–3].
Abbreviations: 6MWD = 6-minute walk distance, FOG =
Freezing of Gait, HY = Hoehn and Yahr, OLS = one-leg stance,
PD = Parkinson disease, PIGD = Postural Instability and Gait
Disorder, SD = standard deviation, TUG = timed up-and-go
(test), UPDRS = Unified Parkinson’s Disease Rating Scale.
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Given noted features of PD, such as reduced stride
length and hypokinesia, 6MWD is reduced in those with
PD as compared with nondisabled adults [5,7]. While
such a patient-control comparison may be of interest, it
may be of additional utility to compare “patients to
patients.” The latter may be useful in understanding the
extent of functional exercise capacity in relation to indi-
viduals who share the same neurological disorder. Con-
sidering the unique factors associated with 6MWD in PD
[5–6], developing predictions specific to individuals with
PD would be valuable. As a result, the following com-
prise the objectives of this study: (1) determine 6MWD
in a large sample of individuals with PD, (2) compare
measured 6MWD with predicted 6MWD from existing
reference equations, and (3) identify factors contributing
to 6MWD and develop a PD-specific reference equation.
Parts of our results have been reported previously (e.g.,
demographics, performance scores) [6], but the objective
and analysis of this report are distinct.
METHODS
Eighty individuals with idiopathic PD [8] were
recruited from the Washington University Movement
Disorders Clinic. Subjects were excluded if they had
other neurological deficits or serious medical issues and/
or were unable to independently ambulate. Demograph-
ics are provided in the Table. All eligible subjects pro-
vided their written informed consent following a health
screening and study briefing. Experimental testing was
approved by the Human Research Protection Office at
the Washington University School of Medicine.
The following data were recorded: (1) anthropometric
variables, (2) the Unified Parkinson’s Disease Rating Scale
(UPDRS) [9], (3) Hoehn and Yahr (HY) scale [10], (4) the
Activities-specific Balance Confidence scale [11], (5) the
Freezing of Gait (FOG) questionnaire [12], (6) one-leg
stance (OLS) test [13], (7) TUG test [14], and (8) the
6-minute walk test [15].
The OLS test assesses balance by having an individ-
ual stand on only his or her preferred leg; the single best
time out of three attempts was used for analysis. The
TUG test is a basic test of functional mobility whereby
the individual rises from a chair, walks 3 m, and then
returns to sit in the chair. Similarly, we used the single
best time out of three attempts. For the 6-minute walk
test, subjects were asked to walk as far as they could
down a 30.5 m corridor for 6 minutes. They were advised
that they could slow down or rest if needed. Spotters
were available to supervise the execution of turns at the
ends of the corridor. To determine whether subjects also
experienced any akinetic blocks or freezing of gait, we
also had them complete the FOG questionnaire.
The Postural Instability and Gait Disorder (PIGD)
subscale, derived from items 27–30 on the UPDRS motor
subsection, was also computed and is thought to repre-
sent clinical mobility [16]. The same clinician also rated
the clinical disability of each subject according to the HY
scale. Scores range from 0 to 5, with 0 indicating no signs
of the disease and 5 being reserved for those who are
wheelchair bound or unable to independently move. A
score of 2 to 3 generally indicates mild to moderate dis-
ease severity and includes bilateral symptoms and pos-
tural instability in some cases.
Collectively, these data were hypothesized to capture
the variance in 6MWD. One should note that height was
not recorded for 38 of our 80 subjects. However, we did
have records of subjects’ leg length, which has been used
previously to estimate height [17]. Using the full data
sets (i.e., known heights) from our 42 subjects, we esti-
mated leg length to be 52 percent of total height and then
applied this parameter to the 38 subjects whose heights
were not directly recorded. (See the “Results” section for
additional discussion.)
Table.
Demographics and performance for 80 participants with Parkinson
disease (PD).
Variable Mean ± SD (Range) r
Sex (No.) 24 female, 56 male –0.33*†
Age (yr) 66.3 ± 9.8 (37.0–83.0) –0.24†
Height (cm) 174.2 ± 10.6 (149.9–195.2) 0.20
Weight (kg) 80.8 ± 19.4 (46.4–156.8) 0.14
PD Duration (yr) 8.6 ± 5.1 (0.3–20.0) –0.02
HY Stage (1–5) 2.3 ± 0.5 (1.0–4.0) –0.40*†
UPDRS Motor (0–108) 28.7 ± 9.4 (4.0–49.0) –0.28†
PIGD Subscale (0–20) 2.8 ± 2.2 (0–10.5) –0.45*†
ABC Scale (0–100) 74.3 ± 20.5 (26.2–100.0) 0.02
FOG Questionnaire (0–24) 7.7 ± 5.7 (0–19.0) –0.34*†
OLS Time (s) 12.3 ± 15.6 (0–60.0) 0.47*†
TUG (s) 10.7 ± 4.7 (5.2–36.6) –0.67*†
6MWD (m) 394.1 ± 98.4 (152.7–613.6) —
*Entered into stepwise regression.
†Significantly correlated with 6MWD (p < 0.05).
6MWD = 6-minute walk distance, ABC = Activities-specific Balance Confi-
dence, FOG = Freezing of Gait, HY = Hoehn and Yahr, OLS = one-leg stance,
PIGD = Postural Instability and Gait Disorder, SD = standard deviation, TUG =
timed up-and-go, UPDRS = Unified Parkinson’s Disease Rating Scale.
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All statistical analyses were performed with SPSS
v17.0 software (Chicago, Illinois). Pearson correlation
coefficients were calculated, and a stepwise multiple
regression was used to determine independent variables
explaining the variance in 6MWD. An additional forced-
entry regression using variables identified in previous
literature (e.g., age, height, weight, and sex) [2–3] was
also performed for comparison purposes. Variables were
allowed to enter the model at the 5 percent level of signifi-
cance. Data were checked for and met the assumptions of
regression (normality, multicollinearity, homoscedasticity,
etc.) and are presented as mean ± standard deviation (SD).
RESULTS
Considerable variability was noted in the 6MWD
(range: 152.7–613.6 m) for individuals with PD (mean
age of 66 yr, HY of 2.3), with an average distance of
394.1 m. Some of this variability may be accounted for
through univariate correlation analysis demonstrating sex,
age, HY stage, UPDRS, TUG, PIGD, FOG, and OLS to
be significantly correlated with 6MWD (r = –0.67 to
0.47, p < 0.05). Coefficients are presented in the Table.
As seen in the Table, height is not significantly correlated
with 6MWD (r = 0.20, p = 0.22) for the entire sample. We
ran an additional correlation for those subjects (n = 42)
for whom height was not estimated and also did not find a
significant relationship (r = 0.17, p = 0.48).
We chose six variables with the largest significant
univariate correlations to enter into our stepwise multiple
regression (i.e., 16 cases per variable). PIGD, OLS,
TUG, FOG, HY, and sex were entered into our stepwise
multiple regressions, and TUG, OLS, and sex were iden-
tified as significant (p < 0.01) independent contributors
to 6MWD, explaining approximately 56.6 percent of the
variance. The largest portion was explained by TUG
(44.7%), followed by OLS time (7.8%) and sex (4.0%).
For predicting 6MWD (6MWDpred), our regression equa-
tion is 6MWDpred = 543.06 + (–10.83 × TUG) + (2.04 ×
OLS) + (–44.44 × sex). (For sex, 0 = female, 1 = male.)
Using predictor variables derived from nondisabled
adults [2–3], we performed a forced-entry regression
analysis and were only able to explain 17.8 percent of the
variance in 6MWD in our sample with PD, compared
with the 56.6 percent that was explained using a stepwise
technique. In addition, we input our data into the existing
equations for nondisabled individuals by using their pub-
lished coefficients and found these equations to signifi-
cantly overestimate mean 6MWD by 57.9 percent on
average (range: 143.2–254.2 m). To further confirm the
appropriateness of our estimated height data, we also sep-
arately analyzed those subjects (n = 42) with full data sets
and found a very similar 58.9 percent overestimation of
6MWD compared with that observed. With the exception
of sex, no variables were common among the previously
reported equations and those found in the present study.
A comparison of observed distance, predicted distance
based on our equation, and predicted distances based on
two existing equations developed from nondisabled popu-
lations (ages 40–85 yr) is presented in Figure (b).
To illustrate the agreement between our observed
scores and predicted scores, a Bland-Altman plot is pre-
sented in Figure (a). The mean ± SD of the differences is
–4.53 ± 114.25 and, therefore, mean ± 2 SD is (–233.04,
223.98). From the plot, only 5/80 points (6.2%) exceed
the ±2 SD demarcations. Although the difference between
mean observed 6MWD (394.1) and predicted 6MWD
(389.5) is small, Figure (a) further illustrates the variability
in 6MWD in those with PD.
DISCUSSION
Our main finding demonstrates that for individuals
with PD, the variance in 6MWD is not accounted for by
anthropometrics, sex, and age, as seen in nondisabled
adults. Therefore, utilizing previously published reference
equations to predict 6MWD is not appropriate for individ-
uals with PD, a finding that is supported by earlier work
[4]. These equations [2–3] were able to explain between
38 and 66 percent of the variance in 6MWD through
height, age, weight, and sex in nondisabled adults. Yet
when we forced the entry of these variables (e.g., age,
height, weight, sex), only 17.8 percent of the variance in
6MWD was explained. However, we report a PD-specific
regression equation that identifies increased fall risk, bal-
ance, and sex as independent contributors to 6MWD and
explains approximately 56.6 percent of the variance. Our
findings support those of Canning et al. [5], which under-
scores the importance of identifying physical impairments
associated with functional exercise capacity (i.e., 6MWD)
that may be directly targeted for future rehabilitation.
It has been suggested previously that interpretation of
6MWD is enhanced when expressed as a percentage of
predicted values as opposed to a single arbitrary distance
1124
JRRD, Volume 46, Number 9, 2009
[3]. However, this suggestion assumed that 6MWD refer-
ence equations were developed with the population of
interest, which was previously not applicable to individu-
als with PD. Utilizing the reference equation of the present
study, future investigations may be able to interpret
6MWD in individuals with PD as a percentage of that pre-
dicted. For example, we may consider an abnormal
6MWD as that which is below the 95 percent confidence
interval. In our sample, this would be a distance of less
than 370 m, which was found for 29 out of 80 subjects. On
average, this equated to a 6MWD that was approximately
40 percent less than that predicted. Such a criterion may be
useful for interpreting functional exercise capacity in indi-
viduals with PD. Therefore, we believe this PD-specific
reference equation may be of utility to clinicians who are
trying to gauge where their patients are performing relative
to what is expected. In addition, clinicians may be able to
provide a realistic therapy goal of attaining a certain per-
cent of predicted 6MWD based on the PD-specific equa-
tion, which is more reasonable than a goal derived from
data on nondisabled older adults [2–3].
Caution is advised when interpreting these results for
several reasons. First, our cross-sectional design may be
prone to selection bias and may overestimate 6MWD in
those with more advanced PD. Based on our average HY
stage, the majority of this sample is mild to moderate in
disease progression. Despite this, our subject characteris-
tics exhibited quite a range (see Table) in many of our
assessments. Further, this is the largest sample of individu-
als with PD (n = 80) to date reporting 6MWD. A second
potential limitation due to our study design is stability or
test-retest reliability of the 6-minute walk test. Although
reliability is of greater concern in those studies utilizing
6MWD as an outcome measurement [7,18], the
reliability of this test in persons with PD is strong and has
been supported in two separate studies (interclass corre-
lation coefficient = 0.95 [19] and 0.96 [20]). Lastly, the 6-
minute walk test is most frequently used in pulmonary and
cardiac settings. Because a substantial portion of variance
(i.e., 43.4%) remains unexplained, we cannot account for
the influence of motivation and preferred walking speed,
which may have contributed noise to these data. In addi-
tion, more sophisticated cardiopulmonary assessments
may provide additional insight for individuals with PD,
and this area is worthy of additional research. However,
the advantage of the variables included in the reference
equation of the present study is that sophisticated tech-
nology is not needed to collect such data.
Performance of the 6-minute walk test varies in indi-
viduals with PD, as evidenced by the range in 6MWD (i.e.,
315–560 m) [4–5,7,17–20] and illustrated in Figure (a). A
portion of this variability may be explained through meas-
ures of fall risk (e.g., TUG) and balance (e.g., OLS), as
well as by sex. This differs from nondisabled adults, for
whom anthropometrics and age are of greater importance.
As a result, utilizing regression equations intended for
Figure.
(a) Bland-Altman plot illustrating agreement between scores observed
(Obs) and scores predicted (Pred) from our equation. SD = standard
deviation. (b) Comparison of our sample’s observed and predicted
6-minute walk distance (6MWD) with those predicted from equations
derived from nondisabled adults. Enright PL, Sherrill DL. Reference
equations for the six-minute walk in nondisabled adults. Am J Resp Crit
Care Med. 1998;158(5 Pt 1):1384–87 [PMID: 9817683]. †Troosters T,
Gosselink R, Decramer M. Six minute walking distance in nondisabled
elderly subjects. Eur Respir J. 1999;14(2):270–74. [PMID: 10515400]
DOI:10.1034/j.1399-3003.1999.14b06.x
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nondisabled adults results in inflated 6MWD estimates for
individuals with PD (see Figure (b)). Despite our findings,
a considerable amount of variability in 6MWD remains to
be explained. Canning et al. previously reported that hypok-
inesia accounted for a large portion of variance in 6MWD
in those with PD [5]. These authors quantified hypokinesia
as the walking velocity recorded while participants walked
as fast as possible over an 8 m walkway. Unfortunately, we
were unable to perform similar measurements to quantify
hyopkinetic walking, which may have accounted for a por-
tion of our unexplained variance. However, we suspect that
the inclusion of the TUG in the present study provides some
utility in describing hypokinesia.
CONCLUSIONS
The PD-specific reference equation presented herein
provides researchers and clinicians the opportunity to
interpret their observed 6MWD with more appropriate
predicted values. Reference equations for nondisabled
adults without PD are inappropriate and do not suffi-
ciently account for the substantial variance in 6MWD for
individuals with PD. Alternatively, factors such as fall
risk, balance, and sex explain approximately 40 percent
more variance than is explained by previously available
reference equations. Additional research is necessary to
confirm the appropriateness of this equation in other
samples and/or identify other factors that help explain a
greater amount of variance in 6MWD.
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